Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Treasury Shares (2016 - 2025)

Prestige Consumer Healthcare has reported Treasury Shares over the past 15 years, most recently at $438.5 million for Q4 2025.

  • Quarterly results put Treasury Shares at $438.5 million for Q4 2025, up 64.96% from a year ago — trailing twelve months through Dec 2025 was $438.5 million (up 64.96% YoY), and the annual figure for FY2025 was $277.2 million, up 26.22%.
  • Treasury Shares for Q4 2025 was $8.9 million at Prestige Consumer Healthcare, up from $8.1 million in the prior quarter.
  • Over the last five years, Treasury Shares for PBH hit a ceiling of $8.9 million in Q4 2025 and a floor of $515000.0 in Q4 2023.
  • Median Treasury Shares over the past 5 years was $5.4 million (2022), compared with a mean of $5.2 million.
  • Biggest five-year swings in Treasury Shares: grew 2.23% in 2022 and later surged 64.96% in 2025.
  • Prestige Consumer Healthcare's Treasury Shares stood at $133.6 million in 2021, then surged by 41.5% to $189.1 million in 2022, then increased by 16.14% to $219.6 million in 2023, then increased by 21.04% to $265.8 million in 2024, then surged by 64.96% to $438.5 million in 2025.
  • The last three reported values for Treasury Shares were $438.5 million (Q4 2025), $392.2 million (Q3 2025), and $316.3 million (Q2 2025) per Business Quant data.